Cited by 297RNA Interference and Gene DeliveryNanoparticle-Based Drug DeliveryCRISPR and Genetic Engineering

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Targeted Delivery of CRISPR/Cas9‐Mediated Cancer Gene Therapy via Liposome‐Templated Hydrogel Nanoparticles

Open access

Chen, Zeming, Liu, Fuyao, Chen, Yanke, Liu, Jun, Wang, Xiaoying, Chen, Ann T., Deng, Gang, Zhang, Hongyi, Liu, Jie, Hong, Zhangyong, Zhou, Jiangbing·2017·Advanced Functional Materials

DOI 10.1002/adfm.201703036PMC PMC5939593

Open this paper in CoChat — free account

Abstract

Due to its simplicity, versatility, and high efficiency, the clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 technology has emerged as one of the most promising approaches for treatment of a variety of genetic diseases, including human cancers. However, further translation of CRISPR/Cas9 for cancer gene therapy requires development of safe approaches for efficient, highly specific delivery of both Cas9 and single guide RNA to tumors. Here, novel core-shell nanostructure, liposome-templated hydrogel nanoparticles (LHNPs) that are optimized for efficient codelivery of Cas9 protein and nucleic acids is reported. It is demonstrated that, when coupled with the minicircle DNA technology, LHNPs deliver CRISPR/Cas9 with efficiency greater than commercial agent Lipofectamine 2000 in cell culture and can be engineered for targeted inhibition of genes in tumors, including tumors the brain. When CRISPR/Cas9 targeting a model therapeutic gene, polo-like kinase 1 (PLK1), is delivered, LHNPs effectively inhibit tumor growth and improve tumor-bearing mouse survival. The results suggest LHNPs as versatile CRISPR/Cas9-delivery tool that can be adapted for experimentally studying the biology of cancer as well as for clinically translating cancer gene therapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/adfm.201703036

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Improved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016
CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., Stern-Ginossar, N., Brandman, O., Whitehead, E. H., Doudna, J. A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.044 · Cited by 3,696
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299
Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo
Zuris, J. A., Thompson, D. B., Shu, Y., Guilinger, J. P., Bessen, J. L., Hu, J. H., Maeder, M. L., Joung, J. K., Chen, Z.-Y., & Liu, D. R. (2015) · Nature Biotechnology · doi:10.1038/nbt.3081 · Cited by 1,460
Self-citation
Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors
Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Girard, O. M., Hanahan, D., Mattrey, R. F., & Ruoslahti, E. I. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.10.013 · Cited by 1,140
Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing
Tsai, S. Q., Wyvekens, N., Khayter, C., Foden, J. A., Thapar, V., Reyon, D., Goodwin, M. J., Aryee, M. J., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2908 · Cited by 952
CRISPR-mediated direct mutation of cancer genes in the mouse liver
Xue, W., Chen, S., Yin, H., Tammela, T., Papagiannakopoulos, T., Joshi, N. S., Cai, W., Yang, G., Bronson, R., Crowley, D. G., et al. (2014) · Nature · doi:10.1038/nature13589 · Cited by 776

Flagged first, then by citations

Show all 41 references

Research works printed but not linked: 2

10.1126/science.1225829 · DOI · Paper page
10.1038/nmeth.3047 · DOI · Paper page

Sorted by citations

Items 101–200 of 297

Nanotechnology-enabled gene delivery for cancer and other genetic diseases
Jiang, T., Gonzalez, K. M., Cordova, L. E., & Lu, J. (2023) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2200246 · Cited by 45
Liposome-Based Carriers for CRISPR Genome Editing
Yin, X., Harmancey, R., McPherson, D. D., Kim, H., & Huang, S. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612844 · Cited by 44
Autocatalytic Delivery of Brain Tumor–Targeting, Size‐Shrinkable Nanoparticles for Treatment of Breast Cancer Brain Metastases
Zhang, S., Deng, G., Liu, F., Peng, B., Bao, Y., Du, F., Chen, A. T., Liu, J., Chen, Z., Ma, J., et al. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201910651 · Cited by 42
Self-citation
Design and applications of liposome-in-gel as carriers for cancer therapy
Mou, Y., Zhang, P., Lai, W., & Zhang, D. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2139021 · Cited by 44
Review of applications of CRISPR-Cas9 gene-editing technology in cancer research
Zhao, Z., Li, C., Tong, F., Deng, J., Huang, G., & Sang, Y. (2021) · Biological Procedures Online · doi:10.1186/s12575-021-00151-x · Cited by 42
Dual-Responsive Core–Shell Tecto Dendrimers Enable Efficient Gene Editing of Cancer Cells to Boost Immune Checkpoint Blockade Therapy
Liu, J., Li, G., Guo, H., Ni, C., Gao, Y., Cao, X., Xia, J., Shi, X., & Guo, R. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c22584 · Cited by 39
Self-citation
CRISPR/Cas9 Delivery Mediated with Hydroxyl‐Rich Nanosystems for Gene Editing in Aorta
Zhang, X., Chen, X., Gao, S., Li, P., Kong, Y., Li, T., Li, Y., Xu, F., & Du, J. (2019) · Advanced Science · doi:10.1002/advs.201900386 · Cited by 40
Nano-vectors for CRISPR/Cas9-mediated genome editing
Yang, P., Lee, A. Y.-T., Xue, J., Chou, S., Lee, C., Tseng, P., Zhang, T. X., Zhu, Y., Lee, J., Chiou, S., et al. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101482 · Cited by 41
Harnessing function of EMT in hepatocellular carcinoma: From biological view to nanotechnological standpoint
Alqurashi, Y. E., Al‐Hetty, H. R. A. K., Ramaiah, P., Fazaa, A. H., Jalil, A. T., Alsaikhan, F., Gupta, J., Ramírez‐Coronel, A. A., Tayyib, N. A., & Peng, H. (2023) · Environmental Research · doi:10.1016/j.envres.2023.115683 · Cited by 40
Targeted Delivery of Secretory Promelittin via Novel Poly(lactone‐co‐β‐amino ester) Nanoparticles for Treatment of Breast Cancer Brain Metastases
Zhou, Y., Zhang, S., Chen, Z., Bao, Y., Chen, A. T., Sheu, W. C., Liu, F., Jiang, Z., & Zhou, J. (2020) · Advanced Science · doi:10.1002/advs.201901866 · Cited by 38
Self-citation
Non-viral delivery of CRISPR/Cas cargo to the retina using nanoparticles: current possibilities, challenges, and limitations
Salman, A., Kantor, A., McClements, M. E., Marfany, G., Trigueros, S., & MacLaren, R. E. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091842 · Cited by 37
CRISPR/Cas9-based application for cancer therapy: Challenges and solutions for non-viral delivery
Lin, Y., Feng, K.-K., Lu, J.-Y., Le, J., Li, W.-L., Zhang, B., Li, C., Song, X.-H., Tong, L.-W., & Shao, J. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.08.028 · Cited by 38
Cell-membrane coated iron oxide nanoparticles for isolation and specific identification of drug leads from complex matrices
Sherwood, J. A., Sowell, J., Beyer, N., Irvin, J., Stephen, C. A., Antone, A. J., Bao, Y., & Ciesla, L. M. (2019) · Nanoscale · doi:10.1039/c9nr01292c · Cited by 37
CRISPR/Cas9 and Chlorophyll Coordination Micelles for Cancer Treatment by Genome Editing and Photodynamic Therapy
Zhang, C., Wang, X., Liu, G., Ren, H., Liu, J., Jiang, Z., & Zhang, Y. (2023) · Small · doi:10.1002/smll.202206981 · Cited by 36
Self-citation
ZNF117 regulates glioblastoma stem cell differentiation towards oligodendroglial lineage
Liu, J., Wang, X., Chen, A. T., Gao, X., Himes, B. T., Zhang, H., Chen, Z., Wang, J., Sheu, W. C., Deng, G., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29884-3 · Cited by 37
Self-citation
RNA lipid nanoparticles as efficient in vivo CRISPR-Cas9 gene editing tool for therapeutic target validation in glioblastoma cancer stem cells
Rouatbi, N., Walters, A. A., Costa, P. M., Qin, Y., Liam‐Or, R., Grant, V., Pollard, S. M., Wang, J. T.-W., & Al‐Jamal, K. T. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.09.019 · Cited by 36
Realizing Cancer Precision Medicine by Integrating Systems Biology and Nanomaterial Engineering
Joo, J. I., Choi, M., Jang, S., Choi, S. R., Park, S., Shin, D., & Cho, K. (2020) · Advanced Materials · doi:10.1002/adma.201906783 · Cited by 35
Charge-reversal nanocomolexes-based CRISPR/Cas9 delivery system for loss-of-function oncogene editing in hepatocellular carcinoma
Nie, J., Liu, Y., Yu, Q., Zhang, N., Yu, B., Chen, D., Yang, M., & Xu, F. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.03.030 · Cited by 34
Semiconducting Polymer Nanoparticles as Activatable Nanomedicines for Combinational Phototherapy
Xu, M., Zhang, C., Zeng, Z., & Pu, K. (2021) · ACS Applied Polymer Materials · doi:10.1021/acsapm.1c00695 · Cited by 35
Synthetic Vehicles for Encapsulation and Delivery of CRISPR/Cas9 Gene Editing Machinery
Carboni, V., Maaliki, C., Alyami, M., Alsaiari, S. K., & Khashab, N. M. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201800085 · Cited by 34
Strategies and materials of "SMART" non-viral vectors: Overcoming the barriers for brain gene therapy
Li, Y., Liu, L., Ji, W., Peng, H., Zhao, R., & Zhang, X. (2020) · Nano Today · doi:10.1016/j.nantod.2020.101006 · Cited by 34
Eliminating the original cargos of glioblastoma cell-derived small extracellular vesicles for efficient drug delivery to glioblastoma with improved biosafety
Guo, Y., Hu, G., Xia, Y., Li, H., Ji, Y., Zhang, J., Chen, Y., Guo, H., Yang, Y., Wang, Y., et al. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.02.013 · Cited by 33
Self-citation
Pre-clinical non-viral vectors exploited for in vivo CRISPR/Cas9 gene editing: an overview
Rouatbi, N., McGlynn, T., & Al‐Jamal, K. T. (2022) · Biomaterials Science · doi:10.1039/d1bm01452h · Cited by 33
Natural polymer-based hydrogels: versatile biomaterials for biomedical applications
Angaria, N., Saini, S., Hussain, M. S., Sharma, S., Singh, G., Khurana, N., & Kumar, R. (2024) · International Journal of Polymeric Materials · doi:10.1080/00914037.2023.2301645 · Cited by 32
One-in-one individual package and delivery of CRISPR/Cas9 ribonucleoprotein using apoferritin
Pan, X., Pei, X., Huang, H., Su, N., Wu, Z., Wu, Z., & Qi, X. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.08.015 · Cited by 32
Self-Assembled Hydrogel Microparticle-Based Tooth-Germ Organoids
Bektas, C. K., Zhang, W., Mao, Y., Wu, X., Kohn, J., & Yelick, P. C. (2022) · Bioengineering · doi:10.3390/bioengineering9050215 · Cited by 32
Research Progress on Nanoparticles-Based CRISPR/Cas9 System for Targeted Therapy of Tumors
Nie, D., Guo, T., Yue, M., Li, W., Zong, X., Zhu, Y., Huang, J., & Lin, M. (2022) · Biomolecules · doi:10.3390/biom12091239 · Cited by 33
Bioinspired Spatiotemporal Management toward RNA Therapies
Ma, Y., Li, S., Lin, X., & Chen, Y. (2023) · ACS Nano · doi:10.1021/acsnano.3c08219 · Cited by 32
Self-citation
Precisely Targeted Nanoparticles for CRISPR-Cas9 Delivery in Clinical Applications
Liu, X., Gao, M., & Bao, J. (2025) · Nanomaterials · doi:10.3390/nano15070540 · Cited by 31
Tumor-microenvironment activated duplex genome-editing nanoprodrug for sensitized near-infrared titania phototherapy
Li, Z., Pan, Y., Du, S., Li, Y., Chen, C., Song, H., Wu, Y., Luan, X., Xu, Q. H., Guan, X., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.06.016 · Cited by 31
Multifunctional Vector for Delivery of Genome Editing Plasmid Targeting β-Catenin to Remodulate Cancer Cell Properties
He, X., Liu, B., Peng, Y., Zhuo, R., & Cheng, S. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b17481 · Cited by 31
Mutation-Directed Therapeutics for Neurofibromatosis Type I
Leier, A., Bedwell, D. M., Chen, A. T., Dickson, G., Keeling, K. M., Kesterson, R. A., Korf, B. R., Marquez‐Lago, T. T., Müller, U. F., Popplewell, L. J., et al. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.04.012 · Cited by 32
Self-citation
Non-viral nanocarriers for CRISPR-Cas9 gene editing system delivery
Tang, X., Wang, Z., Zhang, Y., Mu, W., & Han, X. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.135116 · Cited by 30
Nanodevices for the Efficient Codelivery of CRISPR-Cas9 Editing Machinery and an Entrapped Cargo: A Proposal for Dual Anti-Inflammatory Therapy
García‐Fernández, A., Vivo‐Llorca, G., Sancho, M., García-Jareño, A. B., Ramírez‐Jiménez, L., Barber‐Cano, E., Murguía, J. R., Orzáez, M., Sancenón, F., & Martínez‐Máñez, R. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071495 · Cited by 31
Peptide and Aptamer Decorated Delivery System for Targeting Delivery of Cas9/sgRNA Plasmid To Mediate Antitumor Genome Editing
Liu, B., He, X., Xu, C., Ren, X., Zhuo, R., & Cheng, S. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b05772 · Cited by 30
New Insights into the Therapeutic Applications of CRISPR/Cas9 Genome Editing in Breast Cancer
Ahmed, M., Daoud, G. H., Mohamed, A., & Harati, R. (2021) · Genes · doi:10.3390/genes12050723 · Cited by 31
Synergy of nanocarriers with CRISPR-Cas9 in an emerging technology platform for biomedical appliances: Current insights and perspectives
Bhattacharjee, R., Jana, A., Nandi, A., Sinha, A., Bhattacharjee, A., Mitra, S., Kar, S., Dey, A., Singh, S. K., Varma, R. S., et al. (2022) · Materials & Design · doi:10.1016/j.matdes.2022.111415 · Cited by 29
Multifunctional Nanocarriers for Alzheimer’s Disease: Befriending the Barriers
Ansari, M. A., Tripathi, T., Venkidasamy, B., Monziani, A., Rajakumar, G., Alomary, M. N., Alyahya, S. A., Onimus, O., D’souza, N., Barkat, M. A., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03730-z · Cited by 29
The emerging landscape of nanotheranostic-based diagnosis and therapy for osteoarthritis
Xiao, S., & Chen, L. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.11.007 · Cited by 29
Advances in Lipid‐Based Codelivery Systems for Cancer and Inflammatory Diseases
Jogdeo, C. M., Panja, S., Kanvinde, S., Kapoor, E., Siddhanta, K., & Oupický, D. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202202400 · Cited by 28
Long-acting therapeutic delivery systems for the treatment of gliomas
Padmakumar, S., & Amiji, M. M. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114853 · Cited by 28
Advances in drug delivery systems based on liposome-composite hydrogel microspheres
Yang, S., Li, Y., Li, S., Zhang, J., Huang, J., Ren, J., & Wu, X. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb01369k · Cited by 27
Suicide gene delivery by morphology-adaptable enantiomeric peptide assemblies for combined ovarian cancer therapy
Song, N., Sun, Z., Wang, B., Liu, X., Hu, B., Chen, N., Zhang, S., & Yu, Z. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.12.020 · Cited by 27
Innovative Precision Gene‐Editing Tools in Personalized Cancer Medicine
Dai, X., Blancafort, P., Wang, P., Sgro, A., Thompson, E. W., & Ostrikov, K. (2020) · Advanced Science · doi:10.1002/advs.201902552 · Cited by 28
Exploring Advanced CRISPR Delivery Technologies for Therapeutic Genome Editing
Rostami, N., Gomari, M. M., Choupani, E., Abkhiz, S., Fadaie, M., Eslami, S. S., Mahmoudi, Z., Zhang, Y., Puri, M., Monfared, F. N., et al. (2024) · Small Science · doi:10.1002/smsc.202400192 · Cited by 27
Cyclodextrin-based delivery systems for chemical and genetic drugs: Current status and future
Gao, Y., Sun, L., Qiao, C., Liu, Y., Wang, Y., Feng, R., Zhang, H., & Zhang, Y. (2024) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2024.123174 · Cited by 28
Self-citation
Lipid and polymer mediated CRISPR/Cas9 gene editing
Gong, Y., Tian, S., Yang, X., & Zhang, S. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb00207k · Cited by 25
Scaffold-based non-viral CRISPR delivery platform for efficient and prolonged gene activation to accelerate tissue regeneration
Zhong, C., He, S., Huang, Y., Yan, J., Wang, J., Liu, W., Fang, J., & Ren, F. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.10.029 · Cited by 24
Advances in Hydrogels of Drug Delivery Systems for the Local Treatment of Brain Tumors
Yang, J., Wang, Z., Ma, C., Tang, H., Hao, H., Li, M., Luo, X., Yang, M., Gao, L., & Li, J. (2024) · Gels · doi:10.3390/gels10060404 · Cited by 24
Topical delivery of chemotherapeutic drugs using nano-hybrid hydrogels to inhibit post-surgical tumour recurrence
Liu, C., Ma, Y., Guo, S., He, B., & Jiang, T. (2021) · Biomaterials Science · doi:10.1039/d0bm01766c · Cited by 25
E7-Targeted Nanotherapeutics for Key HPV Afflicted Cervical Lesions by Employing CRISPR/Cas9 and Poly (Beta-Amino Ester)
Xiong, J., Tan, S., Long, Y., Shen, H., Qu, S., Zhang, C., Ren, C., Zhu, D., & Wang, H. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s335277 · Cited by 24
Stimuli-responsive polymer-complexed liposome nanocarrier provides controlled release of biomolecules
Yang, E., Jung, H., & Chang, P. (2021) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2021.107397 · Cited by 24
Biomimetic gene editing system for precise tumor cell reprogramming and augmented tumor therapy
Qiao, L., Gao, M., Yi, X., Peng, H., Zhang, R., Yao, W., Sun, G., & He, X. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.03.020 · Cited by 25
Breaking the barrier: Nanoparticle-enhanced radiotherapy as the new vanguard in brain tumor treatment
Liu, S., Li, M. J., Liang, B., Sun, W., Shao, Y., Hu, X., & Xing, D. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1394816 · Cited by 23
A novel spherical GelMA-HAMA hydrogel encapsulating APET×2 polypeptide and CFIm25-targeting sgRNA for immune microenvironment modulation and nucleus pulposus regeneration in intervertebral discs
Yu, X., Zhao, Y.-T., Abudouaini, H., Zou, P., Li, L., Bai, X., Wang, S., Guan, J., Li, M., Wang, X., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02783-z · Cited by 23
Self-citation
Activating Mutation of SHP2 Establishes a Tumorigenic Phonotype Through Cell-Autonomous and Non-Cell-Autonomous Mechanisms
Dong, L., Han, D. W., Meng, X., Xu, M., Zheng, C., & Qin, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.630712 · Cited by 23
Polyamidoamine Dendrimer Grafted with an Acid-Responsive Charge-Reversal Layer for Improved Gene Delivery
Wang, J., Cooper, R. C., & Yang, H. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c00580 · Cited by 23
CRISPR Technology in Disease Management: An Updated Review of Clinical Translation and Therapeutic Potential
Far, B. F., Akbari, M., Habibi, M. A., Katavand, M., & Nasseri, S. (2025) · Cell Proliferation · doi:10.1111/cpr.70099 · Cited by 23
Hydrogel-based drug delivery systems for enhanced tumor therapy
Tian, S., Yang, S., & Liu, Y. (2026) · RSC Advances · doi:10.1039/d5ra08269b · Cited by 23
Bioreducible, arginine-rich polydisulfide-based siRNA nanocomplexes with excellent tumor penetration for efficient gene silencing
Zhang, X., Hong, K., Sun, Q., Zhu, Y., & Du, J. (2021) · Biomaterials Science · doi:10.1039/d1bm00643f · Cited by 22
Reversal of tumor malignization and modulation of cell behaviors through genome editing mediated by a multi-functional nanovector
Liu, B., He, X., Zhuo, R., & Cheng, S. (2018) · Nanoscale · doi:10.1039/c8nr07321j · Cited by 22
Activatable luminescent probes for imaging brain diseases
Li, Z., Wang, C., Zhang, M., Li, S., Mao, Z., & Liu, Z. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101239 · Cited by 23
Polymer Network-Based Nanogels and Microgels: Design, Classification, Synthesis, and Applications in Drug Delivery
Sutradhar, S. C., Banik, N., Bari, G. A. K. M. R., & Jeong, J.-H. (2025) · Gels · doi:10.3390/gels11090761 · Cited by 21
Development of non-viral vectors for neuronal-targeted delivery of CRISPR-Cas9 RNA-proteins as a therapeutic strategy for neurological disorders
Shalaby, K. E., Aouida, M., Gupta, V., Abdesselem, H., & El‐Agnaf, O. M. A. (2022) · Biomaterials Science · doi:10.1039/d2bm00368f · Cited by 21
Peptide-Based Therapeutics in Cancer Therapy
Jalil, A. T., Abdulhadi, M. A., Al-Ameer, L. R., Taher, W. M., Abdulameer, S. J., Abosaooda, M., & Fadhil, A. A. (2023) · Molecular Biotechnology · doi:10.1007/s12033-023-00873-1 · Cited by 21
Versatile modification of the CRISPR/Cas9 ribonucleoprotein system to facilitate in vivo application
Sun, B., Chen, H., & Gao, X. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.08.007 · Cited by 20
Knock-In of a Large Reporter Gene via the High-Throughput Microinjection of the CRISPR/Cas9 System
Chen, S., Jiao, Y., Pan, F., Guan, Z., Cheng, S. H., & Sun, D. B. (2022) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2022.3149530 · Cited by 21
Non-viral approaches for gene therapy and therapeutic genome editing across the blood–brain barrier
Xie, R., Wang, Y., Burger, J. C., Li, D., Zhu, M., & Gong, S. (2023) · Med-X · doi:10.1007/s44258-023-00004-0 · Cited by 22
Nature Inspired Delivery Vehicles for CRISPR‐Based Genome Editing
Clarissa, E. M., Karmacharya, M., Choi, H., Kumar, S., & Cho, Y. (2025) · Small · doi:10.1002/smll.202409353 · Cited by 23
Nanotechnological approaches for the targeted delivery of CRISPR-Cas systems for genomic modifications, biomolecular sensing, and precision medicine
Baig, M. M. F. A., Chien, W. T., & Chair, S. Y. (2025) · Biomaterials Science · doi:10.1039/d5bm00711a · Cited by 19
Biomedical Application of Nanogels: From Cancer to Wound Healing
Zafaryab, M., & Vig, K. (2025) · Molecules · doi:10.3390/molecules30102144 · Cited by 20
An Antibody‐CRISPR/Cas Conjugate Platform for Target‐Specific Delivery and Gene Editing in Cancer
Yang, S., Im, S. H., Chung, J. Y., Lee, J. H., Lee, K., Kang, Y. K., & Chung, H. J. (2024) · Advanced Science · doi:10.1002/advs.202308763 · Cited by 18
Smart arginine-equipped polycationic nanoparticles for p/CRISPR delivery into cells
Moradi, P., Hasanzadeh, A., Radmanesh, F., Rajai‐Daryasarei, S., Hosseini, E. S., Kiani, J., Shahbazi, A., Nourizadeh, H., Eslami, M., Dorgalaleh, A., et al. (2021) · Nanotechnology · doi:10.1088/1361-6528/ac357a · Cited by 18
Preparation of carbon dot as a potential CRISPR/Cas9 plasmid delivery system for lung cancer cells
Mohammadinejad, R., Dehshahri, A., Sasan, H., Behnam, B., Ashrafizadeh, M., Gholami, A. S., Pardakhty, A., & Mandegary, A. (2020) · Minerva Biotecnologica · doi:10.23736/s1120-4826.20.02618-x · Cited by 18
Functional Nanoparticles for Enhanced Cancer Therapy
Li, C., Li, Y., Li, G., & Wu, S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081682 · Cited by 18
A review of synergistic strategies in cancer therapy: resveratrol-loaded hydrogels for targeted and multimodal treatment
Fu, Y., Ge, Y., Yi, S., Peng, Q., Jiang, H., & Zhou, J. (2025) · Discover Oncology · doi:10.1007/s12672-025-03079-w · Cited by 18
Self-citation
Synthetic CRISPR/dCas9-KRAB system driven by specific PSA promoter suppresses malignant biological behavior of prostate cancer cells through negative feedback inhibition of PSA expression
Yang, Y., Mei, H., Han, X., Zhang, X., Cheng, J., Zhang, Z., Wang, H., & Xu, H. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00508-y · Cited by 17
Nanoliposomes as nonviral vectors in cancer gene therapy
Yildiz, Ş., Entezari, M., Paskeh, M. D. A., Mirzaei, S., Kalbasi, A., Zabolian, A., Hashemi, F., Hushmandi, K., Hashemi, M., Raei, M., et al. (2024) · MedComm · doi:10.1002/mco2.583 · Cited by 18
Precision oncology revolution: CRISPR-Cas9 and PROTAC technologies unleashed
Kanbar, K., Darzi, R. E., & Jaalouk, D. E. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1434002 · Cited by 17
Methods for CRISPR-Cas as Ribonucleoprotein Complex Delivery In Vivo
Bykonya, A. G., Лавров, А. В., & Smirnikhina, S. (2022) · Molecular Biotechnology · doi:10.1007/s12033-022-00479-z · Cited by 17
Interplay between G protein-coupled receptors and nanotechnology
Jiang, Y., Li, Y., Fu, X., Wu, Y., Wang, R., Zhao, M., Mao, C., & Shi, S. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.07.049 · Cited by 16
Emerging Gene-editing nano-therapeutics for Cancer
Nujoom, N., Koyakutty, M., Biswas, L., Rajkumar, T., & Nair, S. V. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39323 · Cited by 16
Tunable membrane-penetrating bioreductive nanogels based on guanidinylated dendrimers for programmable gene delivery
Zhou, J., Ma, S., Zhang, Y., He, Y., Yang, J., Zhang, H., Luo, K., & Gu, Z. (2020) · Applied Materials Today · doi:10.1016/j.apmt.2020.100646 · Cited by 16
Self-citation
Design of Liposome Formulations for CRISPR/Cas9 Enzyme Immobilization: Evaluation of 5-Alpha-Reductase Enzyme Knockout for Androgenic Disorders
Akbaba, H., Erel‐Akbaba, G., Başpınar, Y., & Şentürk, Ş. (2023) · ACS Omega · doi:10.1021/acsomega.3c07138 · Cited by 15
Triple‐Targeting Delivery of CRISPR/Cas9 To Reduce the Risk of Cardiovascular Diseases
Zhang, L., Wang, L., Xie, Y., Wang, P., Deng, S., Qin, A., Zhang, J., Yu, X., Zheng, W., & Jiang, X. (2019) · Angewandte Chemie · doi:10.1002/ange.201903618 · Cited by 15
Engineering stimuli-responsive nanocarriers for CRISPR/Cas9 genome editing: next-generation cancer therapeutics
Mehnath, S. (2025) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgaf127 · Cited by 14
Hydrogels in Gene Delivery Techniques for Regenerative Medicine and Tissue Engineering
Xu, K., Zhang, Q., Zhu, D., & Jiang, Z. (2024) · Macromolecular Bioscience · doi:10.1002/mabi.202300577 · Cited by 16
Double-Network Nanogel as a Nonviral Vector for DNA Delivery
Ye, M., Wang, Y., Zhao, Y., Xie, R., Yodsanit, N., Johnston, K. E., & Gong, S. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b12492 · Cited by 14
BSA-PEI Nanoparticle Mediated Efficient Delivery of CRISPR/Cas9 into MDA-MB-231 Cells
Rahimi, H., Zaboli, K. A., Thekkiniath, J., Mousavi, S. H., Johari, B., Hashemi, M. R., Nosrati, H., Goldschneider, D., Bernet, A., Danafar, H., et al. (2022) · Molecular Biotechnology · doi:10.1007/s12033-022-00514-z · Cited by 14
Non-viral CRISPR activation system targeting VEGF-A and TGF-β1 for enhanced osteogenesis of pre-osteoblasts implanted with dual-crosslinked hydrogel
Chen, G., Deng, S., Zuo, M., Wang, J., Cheng, D., & Chen, B. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100356 · Cited by 14
Amphiphilic Cationic Peptide-Coated PHA Nanosphere as an Efficient Vector for Multiple-Drug Delivery
Zhang, F., Zhang, C., Fu, S., Liu, H., Han, M., Fan, X., Zhang, H., & Li, W. (2022) · Nanomaterials · doi:10.3390/nano12173024 · Cited by 14
Self-citation
Advances in liposome-based delivery of RNA therapeutics for cancer treatment
Sanati, M., Afshari, A. R., Ahmadi, S. S., Kesharwani, P., & Sahebkar, A. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2023.12.010 · Cited by 14
Recent advances on brain drug delivery via nanoparticles: alternative future materials for neuroscience applications; a review
Razavi, R., khajouei, G., Divsalar, F., Dawi, E. A., & Amiri, M. (2025) · Reviews in the Neurosciences · doi:10.1515/revneuro-2024-0086 · Cited by 14
Bacterium-mimicking sequentially targeted therapeutic nanocomplexes based on O-carboxymethyl chitosan and their cooperative therapy by dual-modality light manipulation
Zhou, J., Ma, S., Zhang, Y., He, Y., Mao, H., Yang, J., Zhang, H., Luo, K., Gong, Q., & Gu, Z. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.118030 · Cited by 13
Self-citation
Effective Genome Editing Using CRISPR‐Cas9 Nanoflowers
Zhang, C., Ren, H., Liu, G., Li, J., Wang, X., & Zhang, Y. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202102365 · Cited by 13
Self-citation
Enhancement of Gene Editing and Base Editing with Therapeutic Ribonucleoproteins through In Vivo Delivery Based on Absorptive Silica Nanoconstruct
Kim, S., Jeong, Y. K., Cho, C. S., Lee, S., Sohn, C. H., Kim, J. H., Jeong, Y., Jo, D. H., Bae, S., & Lee, H. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202201825 · Cited by 13
Recent progress in nanomedicines for imaging and therapy of brain tumors
Hasan, I., Roy, S., Guo, B., Du, S., Tao, W., & Chang, C. (2022) · Biomaterials Science · doi:10.1039/d2bm01572b · Cited by 13
Improving therapeutic potential of non-viral minimized DNA vectors
Arevalo-Soliz, L. M., Hardee, C. L., Fogg, J. M., Corman, N. R., Noorbakhsh, C., & Zechiedrich, L. (2020) · Cell and Gene Therapy Insights · doi:10.18609/cgti.2020.163 · Cited by 14
Overcoming barriers and shaping the future: Challenges and innovations in nucleic acid therapies for Glioblastoma
Zam, A., Rouatbi, N., Walters, A. A., & Al‐Jamal, K. T. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115759 · Cited by 13
PAR2 deficiency tunes inflammatory microenvironment to magnify STING signalling for mitigating cancer metastasis via anionic CRISPR/Cas9 nanoparticles
Fu, X., Li, J., Wu, Y., Mao, C., & Jiang, Y. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.10.017 · Cited by 12

Authors: Chen, Z., Liu, F., Chen, Y., Liu, J., Wang, X., Chen, A. T., Deng, G., Zhang, H., Liu, J., Hong, Z., & Zhou, J.
Affiliations: Nankai University (CN)
Yale University (US)
Corresponding author: Hong, Zhangyong
Zhou, Jiangbing
ORCID: Chen, Zeming
Liu, Fuyao
Chen, Yanke
Liu, Jun
Deng, Gang
Zhang, Hongyi
Liu, Jie
Hong, Zhangyong
Zhou, Jiangbing
Venue: Advanced Functional Materials
Publisher: Wiley
Published: 2017-10-16
Volume: 27
Issue: 46
ISSN: 1616-301X (ISSN-L)
1616-3028
DOI: 10.1002/adfm.201703036
PMC: PMC5939593
OpenAlex: W2766680713
Cited by: 297
References: 41
Citations by year: 2026: 11 · 2025: 44 · 2024: 26 · 2023: 39 · 2022: 60 · 2021: 37 · 2020: 39 · 2019: 24 · 2018: 16
FWCI: 8.83
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Advanced Functional Materials (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (NS095817, NS095147)
American Brain Tumor Association
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
Keywords: CRISPR/Cas9, cancer gene therapy, core-shell nanoparticles, nucleic acid delivery, DNA minicircles, single guide RNA, targeted tumor delivery, brain tumors, PLK1, tumor growth inhibition

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Targeted Delivery of CRISPR/Cas9‐Mediated Cancer Gene Therapy via Liposome‐Templated Hydrogel Nanoparticles

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks